![conference banner](/images/conference-banner.jpeg)
Abstract
Background: Diabetes mellitus, the widely prevalent disease of pancreas, is a metabolic disorder caused by autoimmune destruction of β cells or insulin insufficiency or insulin resistance. Replacement of damaged β cells by cell therapy can mitigate the condition and re-establish normal metabolic control. This has opened up new horizons for research, such as stem cells, cellular reprogramming and β cell regeneration.
Objective: The goal of the study was to summarize the available literature on the use of stem cells for the regeneration of pancreatic β cells and treatment of diabetes mellitus.
Results and Conclusion: Stem cells are exceptional having the potential to self renew and differentiate in many lineages. Stem cells hold tremendous potential to regenerate β cells and treat diabetes mellitus but many milestones on the way are yet to be achieved. But researchers do believe that stem cells and regenerative medicines will be widely used in clinical practices and possibly new effective methodology would be designed for even cure, mitigate and reduce the social burden of diabetes mellitus.
Keywords: Diabetes mellitus, embryonic stem cells (ESCs), adult stem cells, pancreatic stem cells, induced pluripotent stem cells (IPSCs), mesenchymal stem cells (MSCs).
Current Stem Cell Research & Therapy
Title:Translating the Potential of Stem Cells for Diabetes Mellitus: Challenges and Opportunities
Volume: 12 Issue: 8
Author(s): Muhammad Shareef Masoud*, Muhammad Qasim and Muhammad Umar Ali
Affiliation:
- Department of Bioinformatics and Biotechnology, Government College University, Faisalabad, Allama Iqbal Road, 38000,Pakistan
Keywords: Diabetes mellitus, embryonic stem cells (ESCs), adult stem cells, pancreatic stem cells, induced pluripotent stem cells (IPSCs), mesenchymal stem cells (MSCs).
Abstract: Background: Diabetes mellitus, the widely prevalent disease of pancreas, is a metabolic disorder caused by autoimmune destruction of β cells or insulin insufficiency or insulin resistance. Replacement of damaged β cells by cell therapy can mitigate the condition and re-establish normal metabolic control. This has opened up new horizons for research, such as stem cells, cellular reprogramming and β cell regeneration.
Objective: The goal of the study was to summarize the available literature on the use of stem cells for the regeneration of pancreatic β cells and treatment of diabetes mellitus.
Results and Conclusion: Stem cells are exceptional having the potential to self renew and differentiate in many lineages. Stem cells hold tremendous potential to regenerate β cells and treat diabetes mellitus but many milestones on the way are yet to be achieved. But researchers do believe that stem cells and regenerative medicines will be widely used in clinical practices and possibly new effective methodology would be designed for even cure, mitigate and reduce the social burden of diabetes mellitus.
Export Options
About this article
Cite this article as:
Masoud Shareef Muhammad *, Qasim Muhammad and Ali Umar Muhammad, Translating the Potential of Stem Cells for Diabetes Mellitus: Challenges and Opportunities, Current Stem Cell Research & Therapy 2017; 12 (8) . https://dx.doi.org/10.2174/1574888X12666170823112912
DOI https://dx.doi.org/10.2174/1574888X12666170823112912 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Gut-Brain Axis and Metabolism in Polycystic Ovary Syndrome
Current Pharmaceutical Design Requirements and Perspectives for Integrating Metabolomics with other Omics Data
Current Metabolomics Editorial (Hot Topic: Hypertension: A Serious Complication in Pregnancy)
Current Hypertension Reviews Calorie Restriction and Dietary Restriction Mimetics: A Strategy for Improving Healthy Aging and Longevity
Current Pharmaceutical Design Gene Therapy to Improve High-Density Lipoprotein Metabolism and Function
Current Pharmaceutical Design Treatment of Diabetic Cardiovascular Autonomic, Peripheral and Painful Neuropathy. Focus on the Treatment of Cardiovascular Autonomic Neuropathy with ACE Inhibitors
Current Vascular Pharmacology Annexins as Neuroprotective Agents in the Central Nervous System
Current Medicinal Chemistry - Central Nervous System Agents Current Perspectives on Anti-Aging Interventions
Letters in Drug Design & Discovery Diagnosis and Management of Chronic Coronary Artery Disease
Current Cardiology Reviews Prolonged Air Leak After Lung Resection
Current Respiratory Medicine Reviews Neuropeptide/Receptor Expression and Plasticity in Micturition Pathways
Current Pharmaceutical Design Diabetes Trends in Hospitalized HIV-Infected Persons in the United States, 1994-2004
Current HIV Research Role of Iron Deficiency and Overload in the Pathogenesis of Diabetes and Diabetic Complications
Current Medicinal Chemistry A Contemporary Approach to Macular Edema Treatment in Retinal Vein Occlusion
Vascular Disease Prevention (Discontinued) Heat Shock Protein-60 and Risk for Cardiovascular Disease
Current Pharmaceutical Design The Heme Oxygenase/Biliverdin Reductase Pathway in Drug Research and Development
Current Drug Metabolism Attenuating Diabetes: What Really Works?
Current Diabetes Reviews Oxidative Stress and Neurodegenerative Diseases: Looking for a Therapeutic Solution Inspired on Benzopyran Chemistry
Current Topics in Medicinal Chemistry Nutrition and Bone Health: Its Relationship to Osteoporosis
Current Nutrition & Food Science Apoptosis and Oxidative Stress-Related Diseases: The p66Shc Connection
Current Molecular Medicine